Fig. 2: Functional characteristics and characteristics with respect to symptoms of the clusters based on the transdiagnostic and individual clustering analyses in the discovery sample. | Neuropsychopharmacology

Fig. 2: Functional characteristics and characteristics with respect to symptoms of the clusters based on the transdiagnostic and individual clustering analyses in the discovery sample.

From: Transdiagnostic subgroups of cognitive impairment in early affective and psychotic illness

Fig. 2

Functioning differences (A) and psychotic and depressive symptom differences (B, C) of impaired (shades of blue) and spared (shades of green) clusters for the clusterings based on recent-onset depression patients (ROD), recent-onset psychosis patients (ROP) and clinical high-risk individuals (CHR) separately. For comparison impaired and spared clusters of the transdiagnostic cluster solution are shown in gray. Abbreviations: GAF S global assessment of functioning (symptom scale), PANSS positive and negative syndrome scale, BDI Beck’s depression inventory.

Back to article page